Achilles Therapeutics PLC (ACHL)
0.93
+0.01
(+1.63%)
USD |
NASDAQ |
May 17, 16:00
0.93
0.00 (0.00%)
After-Hours: 20:00
Achilles Therapeutics Total Liabilities (Quarterly): 15.39M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.39M |
| December 31, 2023 | 19.09M |
| September 30, 2023 | 21.85M |
| June 30, 2023 | 24.06M |
| March 31, 2023 | 22.46M |
| December 31, 2022 | 23.31M |
| September 30, 2022 | 24.73M |
| Date | Value |
|---|---|
| June 30, 2022 | 26.13M |
| March 31, 2022 | 25.74M |
| December 31, 2021 | 27.58M |
| September 30, 2021 | 24.89M |
| June 30, 2021 | 29.52M |
| March 31, 2021 | 27.05M |
| December 31, 2020 | 29.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.39M
Minimum
Mar 2024
29.55M
Maximum
Dec 2020
24.38M
Average
24.81M
Median
Total Liabilities (Quarterly) Benchmarks
| Barinthus Biotherapeutics PLC | 27.47M |
| TC BioPharm (Holdings) PLC | 7.957M |
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.74M |
| Shareholders Equity (Quarterly) | 130.35M |